Total Payments
$5,863
2024 Payments
$298.81
Companies
7
Transactions
46
Medicare Patients
9,334
Medicare Billing
$4.1M
Payment Breakdown by Category
Other$3,384 (57.7%)
Food & Beverage$2,479 (42.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $3,384 | 6 | 57.7% |
| Food and Beverage | $2,479 | 32 | 42.3% |
| Unspecified | $0 | 8 | 0.0% |
Payments by Type
General
$5,863
38 transactions
Ownership
$0
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $3,384 | 14 | $0 (2024) |
| Alcon Vision LLC | $1,445 | 20 | $0 (2024) |
| Alcon Laboratories Inc | $645.10 | 6 | $0 (2018) |
| Alimera Sciences, Inc. | $232.65 | 2 | $0 (2018) |
| Spark Therapeutics, Inc. | $100.18 | 1 | $0 (2019) |
| Johnson & Johnson Surgical Vision, Inc. | $40.97 | 2 | $0 (2020) |
| Eisai Inc. | $15.75 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $298.81 | 4 | Alcon Vision LLC ($298.81) |
| 2023 | $241.88 | 4 | Alcon Vision LLC ($241.88) |
| 2022 | $1,684 | 8 | US Retina LLC ($1,549) |
| 2021 | $1,481 | 10 | US Retina LLC ($999.88) |
| 2020 | $548.11 | 5 | US Retina LLC ($361.14) |
| 2019 | $732.14 | 5 | US Retina LLC ($473.75) |
| 2018 | $475.39 | 5 | Alcon Laboratories Inc ($358.56) |
| 2017 | $402.36 | 5 | Alcon Laboratories Inc ($286.54) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $56.95 | General |
| Category: Ophthalmology | ||||||
| 09/23/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $149.98 | General |
| Category: Ophthalmology | ||||||
| 06/10/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $91.88 | General |
| Category: Ophthalmology | ||||||
| 2024 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 11/02/2023 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $110.23 | General |
| Category: Ophthalmology | ||||||
| 08/23/2023 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Ophthalmology | ||||||
| 04/20/2023 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $116.67 | General |
| 2023 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 12/01/2022 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $94.25 | General |
| Category: Ophthalmology | ||||||
| 12/01/2022 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: Ophthalmology | ||||||
| 05/25/2022 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Ophthalmology | ||||||
| 05/18/2022 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: Ophthalmology | ||||||
| 04/13/2022 | US Retina LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $1,346.77 | General |
| 04/12/2022 | US Retina LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $201.98 | General |
| 03/21/2022 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: Ophthalmology | ||||||
| 2022 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 12/12/2021 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $110.19 | General |
| Category: Ophthalmology | ||||||
| 11/23/2021 | Alcon Vision LLC | FINESSE (Device) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Ophthalmology | ||||||
| 09/08/2021 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Ophthalmology | ||||||
| 09/07/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Neurology | ||||||
| 07/14/2021 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $138.13 | General |
| Category: Ophthalmology | ||||||
| 06/29/2021 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $59.30 | General |
| Category: Ophthalmology | ||||||
| 05/11/2021 | US Retina LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $868.20 | General |
| 05/06/2021 | US Retina LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $131.68 | General |
| 02/11/2021 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $126.26 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 2,284 | 7,063 | $2.2M | $1.0M |
| 2022 | 10 | 2,173 | 7,065 | $2.3M | $992,413 |
| 2021 | 8 | 2,351 | 7,011 | $2.2M | $980,484 |
| 2020 | 12 | 2,526 | 7,389 | $2.5M | $1.1M |
Total Patients
9,334
Total Services
28,528
Medicare Billing
$4.1M
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 143 | 950 | $1.0M | $646,521 | 62.9% |
| 67028 | Injection of drug into eye | Office | 2023 | 279 | 1,348 | $654,300 | $120,274 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 502 | 775 | $100,750 | $64,321 | 63.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 211 | 1,152 | $97,920 | $63,208 | 64.6% |
| 92134 | Imaging of retina | Office | 2023 | 789 | 2,267 | $167,455 | $61,549 | 36.8% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 14 | 217 | $52,297 | $29,911 | 57.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 187 | 187 | $34,782 | $21,079 | 60.6% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 13 | 15 | $45,550 | $12,035 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 152 | $14,440 | $9,683 | 67.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 70 | 832 | $978,848 | $592,384 | 60.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 274 | 1,338 | $770,850 | $120,599 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 500 | 849 | $110,370 | $71,939 | 65.2% |
| 92134 | Imaging of retina | Office | 2022 | 800 | 2,366 | $189,280 | $65,436 | 34.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 216 | 1,244 | $105,740 | $64,893 | 61.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 202 | 202 | $37,572 | $23,014 | 61.3% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 13 | 133 | $32,053 | $20,987 | 65.5% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 24 | 24 | $76,800 | $20,805 | 27.1% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 12 | 13 | $36,400 | $8,260 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 64 | $6,080 | $4,095 | 67.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 62 | 811 | $955,318 | $598,292 | 62.6% |
| 67028 | Injection of drug into eye | Office | 2021 | 292 | 1,317 | $747,900 | $120,750 | 16.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 556 | 910 | $116,645 | $78,279 | 67.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 227 | 1,214 | $103,190 | $67,791 | 65.7% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 851 | 2,384 | $190,720 | $66,871 | 35.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 212 | 212 | $39,432 | $24,413 | 61.9% |
About Dr. Michael Albert, MD
Dr. Michael Albert, MD is a Ophthalmology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730165325.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Albert, MD has received a total of $5,863 in payments from pharmaceutical and medical device companies, with $298.81 received in 2024. These payments were reported across 46 transactions from 7 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($3,384).
As a Medicare-enrolled provider, Albert has provided services to 9,334 Medicare beneficiaries, totaling 28,528 services with total Medicare billing of $4.1M. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Birmingham, AL
- Active Since 12/16/2005
- Last Updated 06/03/2010
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1730165325
Products in Payments
- Constellation (Device) $1,822
- NGENUITY (Device) $138.13
- Iluvien (Biological) $115.82
- LUXTURNA (Biological) $100.18
- Tecnis 1-piece IOL (Device) $40.97
- Dayvigo (Drug) $15.75
- FINESSE (Device) $13.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Birmingham
Timothy Page, M.d, M.D
Ophthalmology — Payments: $422,616
Ophthalmology $422,616
Dr. Michael Callahan, Md, MD
Ophthalmology — Payments: $29,381
Ophthalmology $29,381
Maria Jancevski, M.d, M.D
Ophthalmology — Payments: $24,652
Ophthalmology $24,652
James Lewis, Md, MD
Ophthalmology — Payments: $18,800
Ophthalmology $18,800
Kristin Bains, M.d, M.D
Ophthalmology — Payments: $17,913
Ophthalmology $17,913
Dr. Marc Michelson, M.d, M.D
Ophthalmology — Payments: $8,951
Ophthalmology $8,951